Project NextGen Selects Initial Vaccine Candidates and Awards Over $500 Million to Advance Development of Vaccines and Therapeutics
BARDA is awarding over $240 million to support Project NextGen clinical studies for COVID-19 vaccines, including investments in cold-chain sample management, genomic sequencing, and increased central laboratory capacity for sample testing.
UF Innovate | Accelerate client BioInfoExperts is among the recipients. BARDA provided $4 million to the startup to provide genomic sequencing of COVID-19.
Oragenics, Inc. Announces Private Placement
Oragenics, a UF startup, is partnering with healthcare investors. They've privately placed 404,728 shares of common stock and 404,728 shares of Series E Mirroring Preferred Stock to fight infectious diseases, including coronaviruses.
Hack #10 | Adaptive Pivots Can Help You Stay Ahead of the Curve
In today’s ever-changing business landscape, the ability to adapt and make strategic pivots is essential for long-term success. Businesses often face challenges such as dry spells, economic uncertainties, and market corrections that necessitate a shift in strategies and operations. Let’s explore three key areas where businesses can pivot to navigate obstacles and growth effectively to stay ahead of the curve.
Pheronym Lands $1 Million National Science Foundation Sbir Phase II Grant
UF Innovate | Accelerate alum, Pheronym, an ag-biotech pest management company, has been awarded a second non-dilutive National Science Foundation (NSF) SBIR Phase II for $1 Million. The grant will fund the final steps to scaling commercial manufacturing of their sustainable, eco-, and climate-friendly approach to pest control. The target pests include Thrips, a globally important pest that developed resistance to chemical pesticides.
Positive Results in Cancer Vaccine Trial for Merkel Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Morphogenesis, Inc., a biotechnology company focused on developing cancer vaccines, in partnership with CohBar, believes they have met their milestone with IFx-HU2.0, a cancer vaccine studied in advanced Merkel cell carcinoma and squamous cell carcinoma.
Dmitry Rinberg on the Mysteries of Smell
"Don't miss this fascinating interview with Dmitry Rinberg, Co-founder and Chief Science Advisor of Canaery, a resident of UF Innovate | Accelerate, as he explores the mysteries of smell with Vasant Dhar. Join AI-pioneer Vasant Dhar as he hosts 'Brave New World' and discover the transformation of humanity by machines in the post-COVID era. The conversation will touch on various topics such as work, health, faith, emotional well-being, government, democracy, and freedom."
MLM Biologics Developing Wound Infection Prevention Device for Military
MLM Biologics Inc., a graduate company of Sid Martin Biotech, has been awarded nearly $1.5 million by the US Army to develop a device that prevents infection in battlefield wounds. The device will utilize MLM Biologic's collagen processing and stabilization technologies. The focus is on preventing infection in complex, traumatic injuries in austere environments. The company plans to incorporate their proprietary technologies and proven anti-inflammatory and anti-microbial components, with potential civilian use in the future.
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
CohBar, Inc. and Morphogenesis, Inc., a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies, have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline.
Entrinsic Bioscience Shares Breakthrough in Rehydration Technology
Groundbreaking research conducted by a team of leading researchers at Entrinsic Bioscience (EBS) and the University of Florida revealed significant findings that will change the way we understand amino acid combinations and represents the next generation of Oral Rehydration Solutions (ORS).
The Transformative Power of Tech Transfer: How One University Makes an Impact Around the Globe
UF Innovate has served as a model for universities nationwide looking to further their tech transfer efforts. UF connects innovators with entrepreneurs, investors and industry experts, while its business incubators (The Hub and Sid Martin Biotech) take research discoveries from the laboratory to the market. Since its inception in 1995, UF Innovate has generated more than $10.4 billion in private investments, launched upwards of 300 startups via tech licensing, and created 7,900-plus startup jobs.
